You are here: vision-research.eu » News » Newsdetails:

Companies announce eye care collaboration

AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.